{"id":"https://openalex.org/W4361815195","doi":"https://doi.org/10.1158/1535-7163.22482146","title":"Supplementary Fig. S1 from Class I \u03b2-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions","display_name":"Supplementary Fig. S1 from Class I \u03b2-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361815195","doi":"https://doi.org/10.1158/1535-7163.22482146"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22482146","doi":"https://doi.org/10.1158/1535-7163.22482146","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22482146","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22482146","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083611272","display_name":"Tracy Y.E. Liaw","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tracy Y.E. Liaw","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016129593","display_name":"Noeris K. Salam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noeris K. Salam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew J. McKay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew J. McKay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051720074","display_name":"Anne Marie Cunningham","orcid":"https://orcid.org/0000-0001-7186-3573","observed_orcids":["https://orcid.org/0000-0001-7186-3573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne M. Cunningham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088845547","display_name":"David E. Hibbs","orcid":"https://orcid.org/0000-0002-2635-2990","observed_orcids":["https://orcid.org/0000-0002-2635-2990"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David E. Hibbs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026784302","display_name":"Maria Kavallaris","orcid":"https://orcid.org/0000-0003-2309-898X","observed_orcids":["https://orcid.org/0000-0003-2309-898X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Kavallaris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.4487000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.4487000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.1923000067472458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.06790000200271606,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-methoxyestradiol","display_name":"2-methoxyestradiol","score":0.9679999947547913},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9160000085830688},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-target-interactions","display_name":"drug-target interactions","score":0.8970000147819519},{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.7580000162124634}],"concepts":[{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.7193054556846619},{"id":"https://openalex.org/C2776260442","wikidata":"https://www.wikidata.org/wiki/Q4596897","display_name":"2-Methoxyestradiol","level":3,"score":0.7034247517585754},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5736480951309204},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5374385118484497},{"id":"https://openalex.org/C84425145","wikidata":"https://www.wikidata.org/wiki/Q422492","display_name":"Tubulin","level":3,"score":0.5096333026885986},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4520443081855774},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4281593859195709},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.33855557441711426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25216910243034363},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.19804391264915466},{"id":"https://openalex.org/C20418707","wikidata":"https://www.wikidata.org/wiki/Q189933","display_name":"Microtubule","level":2,"score":0.15506857633590698}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22482146","doi":"https://doi.org/10.1158/1535-7163.22482146","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22482146","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22482146","doi":"https://doi.org/10.1158/1535-7163.22482146","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22482146","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2099458312","https://openalex.org/W4361815000","https://openalex.org/W2106022704","https://openalex.org/W7095127981","https://openalex.org/W6908502942","https://openalex.org/W2062191002","https://openalex.org/W2143706929","https://openalex.org/W2078307383","https://openalex.org/W1988138622","https://openalex.org/W1482644018"],"abstract_inverted_index":{"Supplementary":[0],"Fig.":[1],"S1":[2],"from":[3],"Class":[4],"I":[5],"\u03b2-tubulin":[6],"mutations":[7],"in":[8],"2-methoxyestradiol-resistant":[9],"acute":[10],"lymphoblastic":[11],"leukemia":[12],"cells:":[13],"implications":[14],"for":[15],"drug-target":[16],"interactions":[17]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-04-05T00:00:00"}